Absci (NASDAQ:ABSI – Free Report) had its price objective cut by KeyCorp from $6.00 to $5.00 in a research note released on Wednesday,Benzinga reports. They currently have an overweight rating on the ...

Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

We recently published a list of 13 AI News and Ratings You Probably Missed. In this article, we are going to take a look at ...

Francis deSouza is Google Cloud’s new chief operating officer. He co-founded AI research startup Synth Labs last year after ...

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...

Churchill Downs Incorporated ("CDI” or "the Company”) announced today that the Company will release fourth quarter and full year 2024 financial results after the market closes on Wednesday, February ...

Absci (ABSI) and Owkin announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for ...